Post

New research · Ophthalmology
Clinics and practice · 4d
ReviewClinics and practice · 2026

Bilateral Iris Metastasis of Small Cell Lung Carcinoma: A Case Report and Systematic Review.

Stipe Vidović, Egon Biuk, Greta Biuk … Dubravka Biuk
Read paper
OphthalmologyReview

Iris metastasis from small cell lung carcinoma carries poor survival

Bilateral Iris Metastasis of Small Cell Lung Carcinoma: A Case Report and Systematic Review.

Stipe Vidović … Dubravka Biuk
Clinics and practice · 2026
Purpose

To report a rare case of bilateral iris metastasis from small cell lung carcinoma (small cell lung carcinoma) and systematically review the literature on small cell lung carcinoma-associated iris metastases, with emphasis on clinical presentation, management, and outcomes.

Methods

Results (Systematic Review): Seventeen studies comprising 17 patients were included; the median age was 60 years, and 64.7% were male.

n = 17 patients
58.3%
Results
58.3%
in eye cancer patients tracked afterward, most died within about 8 months
n = 17 patients
More results

PubMed, ScienceDirect, Scopus, and Web of Science were comprehensively searched on 10 July 2025.

Case report: A 58-year-old woman with previously treated small cell lung carcinoma developed bilateral iris metastases one year after complete remission of the primary tumor.

More results

The median interval from small cell lung carcinoma diagnosis to ocular presentation was 4 months, although iris metastasis was occasionally the initial or concurrent manifestation of disease.

“
Conclusion · 1 of 2

Bilateral iris metastasis from small cell lung carcinoma is rare and may occur as a manifestation of recurrent disease after remission.

Conclusion · 2 of 2

It is an aggressive condition characterized by nonspecific ocular symptoms, variable management, and poor survival, underscoring the importance of early recognition and the need for evidence-based diagnostic and therapeutic strategies.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving